Eli Lilly Diversifies Beyond Weight-Loss Drugs with Four-Billion-Dollar Vaccine Push

Indianapolis, Saturday, 11 July 2026.
Eli Lilly is acquiring three vaccine developers for four billion dollars, shifting its strategy toward infectious diseases as obesity rates begin to level out in wealthy nations.